rs9282671
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000104.4(CYP1B1):c.241T>A(p.Tyr81Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00391 in 1,574,856 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Y81Y) has been classified as Likely benign.
Frequency
Consequence
NM_000104.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP1B1 | NM_000104.4 | c.241T>A | p.Tyr81Asn | missense_variant | 2/3 | ENST00000610745.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP1B1 | ENST00000610745.5 | c.241T>A | p.Tyr81Asn | missense_variant | 2/3 | 1 | NM_000104.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00349 AC: 531AN: 152176Hom.: 3 Cov.: 34
GnomAD3 exomes AF: 0.00355 AC: 654AN: 183970Hom.: 8 AF XY: 0.00381 AC XY: 389AN XY: 101966
GnomAD4 exome AF: 0.00395 AC: 5622AN: 1422562Hom.: 25 Cov.: 35 AF XY: 0.00391 AC XY: 2757AN XY: 705698
GnomAD4 genome ? AF: 0.00348 AC: 530AN: 152294Hom.: 3 Cov.: 34 AF XY: 0.00399 AC XY: 297AN XY: 74480
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | CYP1B1: PM3, PM2:Supporting, PS3:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2021 | Identified in patients with primary congenital glaucoma, primary open-angle glaucoma, coloboma and micropthalmia, but many of these patients were not observed to harbor a second variant in CYP1B1, and Y81N did not segregate with disease in some families. (Melki et al., 2004; Mill et al., 2013; Prokudin et al., 2014; Reis et al., 2016; Rauf et al., 2016); Published functional studies demonstrate a reduction in enzyme activity compared to the wild type (Choudhary et al., 2008; Banerjee et al., 2016); This variant is associated with the following publications: (PMID: 19793111, 27508083, 22004014, 19204079, 19643970, 19234632, 27243976, 27820421, 25646030, 27777502, 23922489, 24281366, 16862072, 18470941, 15342693, 18622259) - |
Primary open angle glaucoma Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2008 | - - |
Anterior segment dysgenesis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jun 11, 2020 | Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as a VUS - 3A. 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0112 - Variants in this gene are known to have reduced penetrance (PMID: 26550445, PMID: 10655546). (N) 0200 - Variant is predicted to result in a missense amino acid change from tyrosine to asparagine (exon 2). (N) 0251 - Variant is heterozygous. (N) 0305 - Variant is present in gnomAD >=0.01 and <0.03 for a recessive condition (772 heterozygotes, 9 homozygotes). (N) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (2 heterozygotes, 0 homozygotes). (N) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (P) 0600 - Variant is located in an annotated domain or motif, (p450 cytochrome domain; PDB, NCBI). (N) 0705 - No comparable variants have previous evidence for pathogenicity. (N) 0808 - Previous reports of pathogenicity are conflicting. This variant has been reported as a VUS and benign, and observed in heterozygote controls or carriers with primary open-angle glaucoma (POAG) (ClinVar, LOVD, PMID: 27777502, PMID: 15342693). However more recently, this variant has been reported as pathogenic in homozygous and compound heterozygous patients with POAG and congenital glaucoma (PMID: 24281366, PMID: 27508083, PMID: 30520782, PMID: 22004014). (N) 1002 - Moderate functional evidence supporting abnormal protein function. Transfected cells demonstrated reduced protein expression (PMID: 18470941). (P) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign - |
Irido-corneo-trabecular dysgenesis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Congenital ocular coloboma Uncertain:1
Uncertain significance, no assertion criteria provided | research | Eye Genetics Research Group, Children's Medical Research Institute | Mar 30, 2012 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 14, 2013 | - - |
Glaucoma 3A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Congenital glaucoma Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at